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Acylation stimulating protein (ASP) is believed to reg-
ulate lipid metabolism in adipocytes. In the search for 
causes of hyperapobetalipoproteinemia, Cianflone et 
al. [1] observed that adipocytes from afflicted patients 
were insensitive to a serum lipogenic factor. This factor, 
which they named ASP, can stimulate triacylglycerol 
synthesis in normal human adipocytes. Following puri-
fication, these researchers determined that ASP is iden-
tical to the complement C3 fragment, C3a, minus its C-
terminal arginine [2]. Purified human ASP (C3a-desArg) 
promotes fatty acid esterification, glucose uptake, and 
diacylglycerol acyltransferase activity in cultured hu-
man fibroblasts and adipocytes [3].
The pig’s regulation of triacylglycerol synthesis is 
of considerable interest both as a model for the human 
and because excessive fat deposition can both increase 
production cost and reduce carcass value of agricultural 
swine. Therefore, we set out to develop methods for the 
study of ASP in the pig. We now report a method for 
purification of ASP from porcine serum.
Materials and methods
Cloning of porcine ASP
Total RNA was extracted from subcutaneous adipose 
tissue obtained at slaughter from male castrate pigs 
(Yorkshire/Landrace/Duroc crossbred, body weight 
~110 kg). A restricted set of porcine cDNA was syn-
thesized from total RNA by reverse transcriptase (RT; 
Superscript II; Gibco BRL, Gaithersburg, MD) de-
rived from two animals using a reverse primer, 5′-
ACAGGAAGCTTGACAWGCTSACHGCCA-3′ which 
flanks the 3′ end of human ASP in the complement 
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Abstract
A method for purifying acylation stimulating protein (ASP) from porcine serum is described. The mRNA encoding 
ASP was cloned by reverse transcriptase-polymerase chain reaction which predicted a 76 residue peptide. Based on 
this sequence, we generated antisera to a C-terminal peptide (ASP1–20) which aided ASP purification. Identity of the 
purified protein was verified by N-terminal sequencing. The molecular mass of porcine ASP is 8926. Porcine ASP 
stimulated esterification of fatty acid into triacylglycerol in cultured human cells with potency similar to that of hu-
man ASP (twofold at 5 μM). Based on this evidence that ASP exists in porcine blood, and that it has acylation stimu-
lating activity, we propose that ASP may play a role in regulation of energy storage in adipose tissue in the pig. 
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Abbreviations: ASP, acylation stimulating protein; BCIP, 5-bromo-4-chloro-3-indolyl phosphate; BSA, bovine serum 
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C3 gene. Three RT reactions were executed. Two re-
actions were independent but used RNA from a com-
mon pig. The third reaction used RNA from a second 
pig. A 228-bp ASP coding region was amplified from 
each set of cDNA by polymerase chain reaction (PCR) 
using the reverse primer above and a forward primer, 
5′-GGYGTGTTYGTGCTGAAYAAGAA-3′, which also 
flanks ASP in the human complement C3 gene [2 and 
4]. The PCR products were cloned into pBluescript 
2KS+ (Invitrogen, Carlsbad, CA) and sequenced using 
T7 and T3 primers at the University of Nebraska DNA 
Sequencing Core Facility with a Li-COR sequencer and 
dye primer chemistry (LI-COR, Lincoln, NE). The PCR 
conditions were: (1) denaturation 3 min at 94 °C; (2) 
one cycle of 15 s at 94 °C, 2 min at 55 °C, and 2 min at 
72 °C; (3) 37 cycles of 15 s at 94 °C, 30 s at 55 °C, and 
30 s at 72 °C; and (4) 7 min extension at 72 °C. All PCRs 
contained 1% DMSO.
ASP Western blot assay
We synthesized a peptide corresponding to the C-ter-
minus of porcine ASP (CEYIAKLRQQHSRNKPLGLA) 
using FMOC-protected amino acids on a Pioneer Pep-
tide Synthesizer (ABI). The synthetic peptide was pu-
rified and conjugated to BSA essentially as described 
earlier [5] and used to immunize a rabbit. Antisera ob-
tained after the fourth boost was used to probe West-
ern blots. Protein samples from 15% SDS–PAGE were 
transferred to nitrocellulose membranes by a semi-dry 
electric transfer apparatus (Semiphor, Kirkegaard and 
Perry Laboratories, Gaithersburg, MD). Membranes 
were incubated with primary antibody raised against 
porcine serum ASP polypeptide (1:500) or a primary 
antibody raised against human plasma ASP (1:1000; 
6). Detection was by anti-rabbit IgG conjugated to al-
kaline phosphatase. The substrates were nitroblue tet-
razolium (NBT) and 5-bromo-4-chloro-3-indolyl phos-
phate (BCIP).
Purification of ASP
Fresh blood was obtained from Yorkshire/Landrace/
Duroc crossbred pigs at slaughter (body weight approx-
imately 110 kg), allowed to clot 4 h at 4 °C, and centri-
fuged 20 min at 4000g. Following the protocol for purifi-
cation of human ASP [7], serum was spiked with inulin 
(0.5% w/v final concentration) and MgCl2 (2 mM final 
concentration) and stirred 1 h at 37 °C to enhance acti-
vation of complement. Globular proteins were precipi-
tated with concentrated HCl (1 M final concentration) 
and separated by centrifugation for 30 min at 4000g. The 
supernatant was neutralized to pH 7.4 by addition of 
10 N NaOH, stored at −20 °C, and used for chromato-
graphic purification of ASP.
The supernatant from the acid precipitation step was 
thawed on ice and applied to a C18 Sep-pak column 
(37–55 μm, 1.5×10 cm; Waters) previously wetted with 3 
volumes methanol and equilibrated with 10 volumes of 
0.1% trifluoroacetic acid (TFA). Unbound proteins were 
removed by washing with 10 volumes of 20% acetoni-
trile (ACN)–0.1% TFA. Bound proteins were eluted with 
6 volumes of 80% ACN–0.1% TFA. One column volume 
fractions were collected. Fractions rich in ASP based on 
15% SDS–PAGE and immunoblotting analysis (gener-
ally fractions one to two) were pooled, lyophilized, and 
redissolved in buffer A (10 mM Tris, 10 mM NaCl, pH 
7.1) plus 0.1% TFA. The dissolved sample was further 
fractionated by cation exchange (Poros PE-Biosystems, 
HS/M, 4.6/100 mm) pre-equilibrated with 10 volumes 
buffer A using an ABI BioCAD Workstation. After wash-
ing with five column volumes of buffer A, bound pro-
teins were eluted with a linear 0–1.5 M gradient of NaCl 
in buffer A at a flow rate of 4 ml/min over 15 column 
volumes. The elution peak (corresponding to 1 M NaCl) 
was pooled and directly loaded into a reversed-phase 
column (Poros PE-Biosystems, R1/H, 4.6×100 mm) pre-
equilibrated with 15% ACN–0.1% TFA using an ABI 
BioCAD workstation. After washing with three col-
umn volumes of 15% ACN–0.1% TFA, bound proteins 
were eluted with a linear gradient from 15% ACN–0.1% 
TFA to 85% ACN–0.1% TFA at a flow rate of 3 ml/min 
over 15 column volumes. Peaks were pooled from sev-
eral runs and lyophilized. Purified porcine ASP was re-
constituted and dialyzed into 10 mM sodium phosphate 
buffer (pH 7.1) and stored frozen (−80 °C). Protein con-
centrations were determined with the BCA Protein As-
say Kit (Pierce, Rockford, IL) using bovine albumin as a 
standard.
Mass spectroscopy
Electrospray mass spectroscopy was performed on puri-
fied ASP obtained after reverse-phase chromatography 
at the University of Nebraska mass spectroscopy core fa-
cility using a Finnigan LCQ ion trap mass spectrometer.
Amino acid sequencing
Approximately 3 μg purified ASP protein was fraction-
ated by 15% SDS–PAGE and electroblotted to a poly-
vinylidene difluoride membrane. The membrane was 
stained with amido black [8] and bands corresponding 
to ASP were excised and sequenced on an ABI-Procise 
494 sequencer using manufacturer-suggested protocols 
for 20 cycles.
Acylation stimulating activity assay
Human skin fibroblasts were plated in Dulbecco’s mod-
ified Eagle’s medium/F12 containing 100 μM [9,10-
3H(N)]oleic acid:BSA (5:1) and grown to 90% conflu-
ence according to Baldo et al. [7]. Cultures were treated 
for 6 h with PBS (n=9); 5 μM human ASP (n=9); or 5 μM 
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porcine ASP (n=3). An organic extract of each culture 
was subjected to thin layer chromatography and triacyl-




The RT-PCR 580-bp product was completely homolo-
gous to porcine complement C3 (Accession No. 110278). 
This sequence exactly matches a subsequent full-length 
clone (Accession No. 154933). The region encoding 
ASP is aligned with human ASP in Figure 1. This re-
gion possibly has two polymorphisms which do not im-
pact amino acid sequence. Base 187 was C versus T and 
base 207 was C versus A in one of the two independent 
clones sequenced. Porcine ASP nucleic acid sequence is 
79.4% homologous to human ([4]; K02765), 72.4% ho-
mologous to mouse ( [9]; K02782), 74.6% homologous to 
rat ( [9]; X52477), and 86.0% homologous to bovine (Ac-
cession No. AF110279). The porcine cDNA predicts a 76-
amino acid ASP sequence which is 75.0, 78.9, 76.3, and 
84.4% similar to human, mouse, rat, and bovine ASP 
amino acid sequences, respectively. 
 
ASP purification
Porcine ASP was obtained from serum in four steps. 
First, complement was activated with inulin and ex-
traneous proteins were acid precipitated. The remain-
ing supernatant was subjected sequentially to C18 chro-
























major peak was eluted by 1 M NaCl in the cation ex-
change column and collected as ASP-rich fractions (Fig-
ure 2A1) based on SDS–PAGE (Figure 2A2) and Western 
blot analyses ( Figure 2A3). Following a second reverse-
phase step in which ASP eluted at approximately 43% 
ACN as a single, dominant peak ( Figure 2B), the re-
sulting porcine ASP was near homogeneity ( Figure 3, 
lane 5). The yield from 400 ml porcine serum was 5.5 mg 
ASP. The relative purification and cumulative ASP yield 
at each step are presented in Table 1 and Figure 3. 
 
ASP characterization
The molecular mass of purified porcine ASP determined 
by mass spectrometry is 8926 which corresponds to the 
calculated mass of the predicted amino acid sequence. 
Porcine ASP migrates slightly faster in 15% SDS–PAGE 
(estimated 8.9 kDa; Figure 4A, lane 1, 2) than human 
ASP, perhaps because human ASP is slightly larger 
(MW=8932). N-terminal sequencing of 20 residues of 
porcine ASP revealed an exact match to the predicted 
sequence (Figure 1). 
Our antisera raised against porcine ASP polypeptide 
do not crossreact with human ASP (Figure 4B, lane 2), 
although it can clearly detect porcine ASP on Western 
blots ( Figure 4B, lane 1). Similarly, the antibody raised 
against purified human ASP [6] does not react strongly 
with porcine ASP on Western blots ( Figure 4C, lane 1). 
Assay of ASP in porcine serum can be made, however, 
if the serum is acid precipitated. We observed that the 
concentration of ASP was elevated in pigs following a 
high fat meal versus following an overnight fast (not 
shown). This compares favorably to the response of ASP 
to fat consumption in humans [10].
Porcine ASP stimulated esterification of oleate into 
triacylglycerol in human fibroblasts. Mean (± SD) esteri-
fication was 108 (± 8.5), 218 (± 16.6), and 217 ± 41.9 pmol 
triacylglycerol/mg cell protein for control, 5 μM human 
ASP, and 5 μM porcine ASP treatments, respectively. 
We have not investigated the mechanism by which por-
cine ASP enhances fatty acid esterification. Presumably 
it functions in the same manner as human ASP. Human 
ASP stimulates diacylglycerol acyltransferase, appar-
ently via protein kinase C signalling from a cell surface 
receptor [13]. The effect of ASP on incorporation of fatty 
acid into triacylglycerol can be attributed to esterifica-
tion. Van Harmelen et al. [14] have reported that, like 
insulin, ASP increases esterification, but unlike insulin, 
ASP does not influence lipolysis. Given the significant 
concurrent cycling of esterification and lipolysis, a small 
increase in esterification will impart a large increase in 
net triacylglycerol accumulation, assuming a constant 
rate of lipolysis. Consequently, the twofold enhance-
ment of esterification caused by porcine ASP is evidence 
that this molecule may be a powerful determinant of 
adipose tissue lipid metabolism. Interestingly, we ob-
served only a modest effect of porcine ASP on lipid syn-
Figure 1. Region of porcine complement C3 cDNA which en-
codes ASP, predicted ASP protein sequence, and alignment 
with human complement C3 [4]. Analysis of two independent 
clones revealed a possible polymorphism at positions 187 (C 
versus T) and 207 (C versus A) which does not affect predicted 
amino acid sequence. The above sequence exactly matches that 
reported by Wimmers et al. [12]. 
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thesis in porcine adipose tissue explant cultures [15]. 
However, this difference in response as compared to the 
cell cultures reported here may be due to technical prob-
lems of making such measurements in tissue pieces ver-
sus monolayers of cells. On the other hand, it remains to 
be demonstrated that porcine adipocytes are responsive 
to porcine ASP.
We conclude that ASP can be obtained from pig 
blood and that porcine ASP exhibits activity comparable 
to ASP derived from human blood. Like human ASP, it 
is resistant to treatment with strong acid and hydropho-
bic treatments. This information should be of value to 
those studying regulation of adiposity in swine, given 
the dearth of hormones known to promote triacylglyc-
erol synthesis in porcine adipose tissue. We propose 
that the complement proteins, ASP and adipsin [16], 
may play a role in regulation of adipose tissue function 
in the pig. 
Figure 2. Purification of ASP from porcine serum. (A1) After primary reverse-phase C18 chromatography, ASP-containing frac-
tions were eluted from a HS/M cation exchange column with a linear 0–1.5 M gradient of NaCl (dashed line) and pooled based on 
SDS–PAGE and Western analyses. Porcine ASP eluted at 1 M NaCl. (A2) The Coomassie brilliant blue-stained 15% SDS–PAGE of 
selected fractions referenced to fraction numbers from panel A1. Each sample was concentrated, desalted, and dissolved in Laem-
mli’s buffer before electrophoresis. A3 Western blot of samples identical to those in panel A2 probed with anti-porcine ASP poly-
peptide antibody. (B) R1H reverse-phase chromatography of ASP-containing fractions from HS/M column. Proteins were eluted 
with a linear 15–85% ACN gradient (dashed line). A sharp, single peak rich in ASP was pooled and lyophilized. 
Figure 3. SDS–PAGE (15%) analysis of chromatographic steps 
in the purification of ASP from porcine serum. Lanes 1 and 6: 
Bio-Rad broad range marker. Lane 2: Clarified supernatant af-
ter acid precipitation and neutralization. Lane 3: Fractions 
pooled from C18 reverse phase. Lane 4: Fractions pooled from 
HS/M cation exchange. Lane 5: Fractions pooled from R1H re-
verse phase. 
Table 1. ASP purification from porcine serum 
Purification step              Proteina (mg )            ASPb (mg)
Serum (400 ml)  28,000  NDc
Neutralized acid 3100  28
   supernatant (246 ml)
C18  30.6  8.0
HS/M  10.2  6.9
R1H  5.5  5.5
a Total protein concentration was determined by the BCA pro-
cedure except that protein content of serum was assumed 
[11].
b ASP protein was quantified by scanning Coomassie blue-
stained SDS–PAGE gels using a Hitachi Genetic Systems In-
strument (Gene-Snap 2.60.0.14; Synoptics; Cambridge, Eng-
land). For the above calculations, the R1H-eluted ASP was 
considered pure and thus used as standard for quantify-
ing ASP in the other samples (CCDBIO Gene-Tools Version 
2.12.05; Hitachi Genetic Systems; Alameda, CA).
c Not determined.
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Figure 4. SDS–PAGE and Western analyses of purified porcine 
and human ASP. (A) SDS–PAGE analysis. Lane 1: Porcine ASP 
(2 μg); Lane 2: Human ASP (2 μg); Lane M: Molecular weight 
markers (kDa). (B) Western blot of the same samples as in 
panel A probed with anti-porcine ASP polypeptide antibody. 
(C) Western blot of the same samples as in panel A probed 
with anti-human ASP antibody. 
